Clinical Trial

Osteogenesis Imperfecta Trial of AGA2115 for ADUlts With COL1A1 and/or COL1A2 GeNetic Variations (IDUN)

Study acronym: IDUN
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This study will determine the effect of treatment of AGA2115 in adults with Type I, III, or IV osteogenesis imperfecta versus placebo.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2025-07-10; most recent amendment 2026-07-08.
Status change: Not Yet Recruiting → Recruiting 2026-01-11
Trial Details
NCT Number NCT07062588
Lead Sponsor Angitia Incorporated Limited
Conditions Osteogenesis Imperfecta (OI)
Enrollment 80 participants
Start Date 2025-12-12
Primary Completion 2027-11 (estimated)
Study Completion 2029-02 (estimated)
Updated on ClinicalTrials.gov 2026-07-09